News | March 02, 2012

FDA Panel Meeting Scheduled for U-Systems’ Automated Breast Ultrasound (ABUS) System

The somo•v Automated Breast Ultrasound is the First Ultrasound Device to Target Breast Cancer Screening Indication

March 2, 2012 — U-Systems announced the somo•v automated breast ultrasound (ABUS) system is scheduled for review by the Radiological Devices Panel of the U.S. Food and Drug Administration (FDA) on April 11, 2012. The FDA Advisory Panel review is the next step in the firm’s premarket approval (PMA) application seeking a breast cancer screening indication for the system. The somo•v ABUS system is currently FDA-cleared for diagnostic use as an adjunct to mammography.

“We are very excited the somo•v ABUS system has been scheduled for review at the upcoming Radiological Devices Advisory Panel meeting,” said Ron Ho, president and CEO of U-Systems. “This is a significant milestone, not only for the company, but also for women with dense breast tissue. The limitation of mammography in women with dense breasts is well documented. This panel review, part of the FDA process for assessing new technology, brings us one step closer to an approved adjunctive screening tool for women with dense breasts. This is vitally important, because an estimated 40-45 percent of women in the United Stated have dense breast tissue.”

Dense breast tissue not only increases the risk of breast cancer up to four to six times but also makes cancer more difficult to detect via mammography according to multiple large studies. A study published in the New England Journal of Medicine showed 35 percent of breast cancer goes undetected by mammography in women with dense breasts, as the density masks appearance of tumors. The greater the breast density, the lower the mammogram accuracy.

Over the past several years, U-Systems has worked with some of the nation’s leading breast imaging experts to conduct a large, multi-center prospective clinical study to evaluate the ability of somo•v automated breast ultrasound screening to improve cancer detection rates for women with dense breast tissue. The SOMO•INSIGHT clinical study, the largest trial ever undertaken by an ultrasound company, is designed to evaluate whether digital mammography in combination with the automated breast ultrasound system is more sensitive than a routine screening mammogram alone in detecting breast cancer in women with dense breast tissue. More than 16,000 women have enrolled in the study at multiple breast imaging centers nationwide.

For more information: www.u-systems.com

Related Content

Novel Technique May Significantly Reduce Breast Biopsies
News | Breast Biopsy Systems | January 17, 2019
A novel technique that uses mammography to determine the biological tissue composition of a tumor could help reduce...
Digital Mammography Increases Breast Cancer Detection
News | Mammography | January 16, 2019
The shift from film to digital mammography increased the detection of breast cancer by 14 percent overall in the United...
Artificial Intelligence Used in Clinical Practice to Measure Breast Density
News | Artificial Intelligence | January 15, 2019
An artificial intelligence (AI) algorithm measures breast density at the level of an experienced mammographer,...
Opto-Acoustic Imaging Helps Differentiate Breast Cancer Molecular Subtypes
News | Ultrasound Women's Health | December 20, 2018
Seno Medical Instruments Inc. (Seno Medical) reported results of a study demonstrating that morphologic and functional...
Densitas Enters Platform Partnership With Blackford
News | Breast Density | December 19, 2018
Breast imaging analytics company Densitas Inc. announced the signing of a new Alliance Partner Agreement with Blackford...
RSNA Study Shows Real-Time Indicator Improves Mammographic Compression
News | Mammography | December 12, 2018
Sigmascreening recently announced that more than 100,000 women have had mammography exams with the Sensitive Sigma...
Massachusetts Superior Court Grants Hologic Preliminary Injunction in Trade Secrets Lawsuits
News | Mammography | December 12, 2018
December 12, 2018 — A Massachusetts Superior Court granted a preliminary injunction in lawsuits by Hologic against Ch
Videos | Mammography | December 10, 2018
Stamatia Destounis, M.D., FACR, associate professor, University of Rochester School of Medicine, and attending radiol
FDA Clears iCAD's ProFound AI for Digital Breast Tomosynthesis
Technology | Mammography | December 07, 2018
iCAD Inc. announced clearance by the U.S. Food and Drug Administration (FDA) for their latest, deep-learning, cancer...
Fujifilm Collaborates With Lunit on AI Pilot Project
News | Artificial Intelligence | December 05, 2018
Fujifilm Medical Systems USA Inc. announced a joint collaboration with Korean-based medical artificial intelligence (AI...